Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma Through the RAS / ERK Signaling Pathway
Weilin Cai,1,2 Minliang Chen2 1Medical School of Chinese PLA, Beijing, People’s Republic of China; 2Senior Department of Burns and Plastic Surgery, the Fourth Medical Center of PLA General Hospital, Beijing, People’s Republic of ChinaCorrespondence: Minliang Chen, Senior Department of Burns and Plas...
Main Authors: | Cai W, Chen M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-03-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/envoplakin-inhibits-macrophage-polarization-by-altering-the-inflammato-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma
by: Marta Morante, et al.
Published: (2022-10-01) -
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
by: Yanlin Song, et al.
Published: (2023-01-01) -
The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Thomas Kubin, et al.
Published: (2020-09-01) -
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
by: Giulia Cesi, et al.
Published: (2017-06-01) -
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
by: Ufuk Degirmenci, et al.
Published: (2020-01-01)